Page last updated: 2024-08-23

simvastatin and Hyperlipoproteinemia Type III

simvastatin has been researched along with Hyperlipoproteinemia Type III in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	8 (88.89)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frants, RR; Gevers Leuven, JA; Havekes, LM; Smelt, AH; Van 't Hooft, FM; Van den Maagdenberg, AM; Van der Laarse, A; Van Tol, A; Vroom, TF; Zhao, SP	1
Guyton, JR	1
Cenarro, A; Civeira, F; Ferrando, J; Garcia-Otín, AL; Mozas, P; Pocoví, M; Puzo, J	1
Gaw, A; Wosornu, D	1
Eichinger, M; Feussner, G; Ziegler, R	1
Mol, MJ; Stalenhoef, AF; Stuyt, PM	1
MacDonald, JL; Mauro, VF	1
Demacker, PN; Mol, MJ; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A	1
Mol, MJ; Stalenhoef, AF; Stuyt, PM; van 't Laar, A	1

Reviews

1 review(s) available for simvastatin and Hyperlipoproteinemia Type III

Article	Year
Simvastatin: a review of its pharmacology and clinical use. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:3 Topics: Adolescent; Adult; Anticholesteremic Agents; Cholesterol; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lovastatin; Simvastatin	1991

Trials

2 trial(s) available for simvastatin and Hyperlipoproteinemia Type III

Article	Year
Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia. American heart journal, 1999, Volume: 138, Issue:1 Pt 1 Topics: Adult; Apolipoproteins; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Treatment Outcome	1999
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia. The Clinical investigator, 1992, Volume: 70, Issue:11 Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides	1992

Article

Year

Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.

American heart journal, 1999, Volume: 138, Issue:1 Pt 1

Topics: Adult; Apolipoproteins; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Treatment Outcome

1999

The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.

The Clinical investigator, 1992, Volume: 70, Issue:11

Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides

1992

Other Studies

6 other study(ies) available for simvastatin and Hyperlipoproteinemia Type III

Article	Year
Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin. Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:11 Topics: Adult; Aged; Apolipoprotein E2; Apolipoprotein E3; Apolipoproteins E; Carrier Proteins; Cholesterol Ester Transfer Proteins; Female; Glycoproteins; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Reference Values; Simvastatin	1994
Treatment of type III hyperlipoproteinemia. American heart journal, 1999, Volume: 138, Issue:1 Pt 1 Topics: Apolipoproteins E; Cholesterol, LDL; Cholesterol, VLDL; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Simvastatin; Treatment Outcome	1999
Simvastatin during warfarin therapy in hyperlipoproteinaemia. Lancet (London, England), 1992, Oct-17, Volume: 340, Issue:8825 Topics: Female; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lovastatin; Middle Aged; Simvastatin; Warfarin	1992
Long-term effects of simvastatin in familial dysbetalipoproteinaemia. Journal of internal medicine, 1991, Volume: 230, Issue:2 Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type III; Lovastatin; Male; Middle Aged; Simvastatin; Time Factors; Triglycerides	1991
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia). The American journal of medicine, 1990, Volume: 88, Issue:1N Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides	1990
Cholesterol synthesis inhibitors in hyperlipidaemia. Lancet (London, England), 1988, Mar-12, Volume: 1, Issue:8585 Topics: Anticholesteremic Agents; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Lovastatin; Male; Middle Aged; Simvastatin	1988